NSEDCP
CLVS
NJ State Employees Deferred Compensation Plan’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,000
| Closed | -$15K | – | 488 |
|
|
2022
Q3 | $15K | Hold |
13,000
| – | – | ﹤0.01% | 475 |
|
|
2022
Q2 | $23K | Hold |
13,000
| – | – | ﹤0.01% | 473 |
|
|
2022
Q1 | $26K | Hold |
13,000
| – | – | ﹤0.01% | 497 |
|
|
2021
Q4 | $35K | Hold |
13,000
| – | – | ﹤0.01% | 500 |
|
|
2021
Q3 | $58K | Hold |
13,000
| – | – | 0.01% | 499 |
|
|
2021
Q2 | $75K | Hold |
13,000
| – | – | 0.01% | 511 |
|
|
2021
Q1 | $91K | Hold |
13,000
| – | – | 0.01% | 506 |
|
|
2020
Q4 | $62K | Hold |
13,000
| – | – | 0.01% | 497 |
|
|
2020
Q3 | $76K | Hold |
13,000
| – | – | 0.01% | 469 |
|
|
2020
Q2 | $88K | Hold |
13,000
| – | – | 0.02% | 474 |
|
|
2020
Q1 | $83K | Hold |
13,000
| – | – | 0.02% | 447 |
|
|
2019
Q4 | $136K | Hold |
13,000
| – | – | 0.02% | 500 |
|
|
2019
Q3 | $51K | Hold |
13,000
| – | – | 0.01% | 528 |
|
|
2019
Q2 | $193K | Hold |
13,000
| – | – | 0.03% | 507 |
|
|
2019
Q1 | $323K | Sell |
13,000
-1,000
| -7% | -$24.8K | 0.06% | 411 |
|
|
2018
Q4 | $251K | Hold |
14,000
| – | – | 0.05% | 418 |
|
|
2018
Q3 | $411K | Buy |
14,000
+1,000
| +8% | +$29.4K | 0.07% | 373 |
|
|
2018
Q2 | $591K | Buy |
13,000
+2,000
| +18% | +$90.9K | 0.11% | 264 |
|
|
2018
Q1 | $581K | Buy |
11,000
+2,000
| +22% | +$106K | 0.1% | 277 |
|
|
2017
Q4 | $612K | Hold |
9,000
| – | – | 0.11% | 277 |
|
|
2017
Q3 | $742K | Buy |
+9,000
| New | +$742K | 0.13% | 232 |
|